Startups Working in ALS, Immunotherapy Win ‘Amgen Golden Tickets’ to Advance Discoveries – ALS News Today
|
Startups Working in ALS, Immunotherapy Win 'Amgen Golden Tickets' to Advance Discoveries
ALS News Today Two young companies, QurAlis and Kernal Biologics, are winners of the Amgen Golden Tickets for innovative bioscience projects — in this case, work that might lead to better treatments in amyotrophic lateral sclerosis (ALS) and cancer immunotherapy … |
